TIG Advisors LLC’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-643,439
Closed -$13.8M 256
2021
Q4
$13.8M Buy
+643,439
New +$12.7M 0.68% 19

Other funds holding OCDX

TIG Advisors LLC's OCDX Position: Q1 2022 in Review

TIG Advisors LLC sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 643,439 shares — an estimated $13.8M sold.

TIG Advisors LLC first reported a position in OCDX in Q4 2021 and held it in 1 quarter. The position peaked at $13.8M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • TIG Advisors LLC reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • TIG Advisors LLC sold 643,439 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $13.8M.
  • TIG Advisors LLC first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • TIG Advisors LLC's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $13.8M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on TIG Advisors LLC's 13F filing for Q1 2022, filed 16 May 2022.